Figure 1From: Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: a case report Volume of ascites and number of transferred cells: (a) Volume of ascites drained and number of DC+AK cells transferred into the hypogastric area. From 16 February 2007 (day 1), we started to drain 3000 ml of ascites and transferred 5.4 × 109 DC+AK cells on day 8. Drainage and intraperitoneal immunotherapy in the hypogastric area continued for 1 month. A total of 13,222 ml of ascites was aspirated. Black bars indicate the volume of ascites, and white arrows, the date of DC+AK immunotherapy. (b) Volume of ascites drained and number of DC+AK cells transferred into the epigastric area. From 23 March 2007 (day 1), we started to drain 2800 ml of ascites and transferred 9.8 × 109 DC+AK cells on day 5. Drainage and intraperitoneal immunotherapy in the epigastric area continued for 1 month. A total of 6000 ml of ascites was aspirated. Black bars indicate the volume of ascites, and white arrows, the date of DC+AK immunotherapy. The gray arrow indicates the date of TIL immunotherapy.Back to article page